Investor's Business Daily on MSN16m
Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble
Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.
Sanofi gets FDA approval for NovoLog insulin biosimilar
Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...